Director Srinivas Akkaraju filed a Form 4 with the SEC on October 27, 2026, disclosing open-market purchases of Scholar Rock Holding Corp common stock on October 23 and October 26, 2026, through two affiliated investment funds.

Key Highlights

  • Reporting person: Srinivas Akkaraju, listed as a Director of Scholar Rock Holding Corp (NASDAQ:SRRK).
  • Transactions on October 23, 2026: Samsara BioCapital, L.P. acquired 47,000 shares at a weighted average price of $41.31 and 500 shares at a weighted average price of $41.82; Samsara Opportunity Fund, L.P. acquired 94,000 shares at $41.31 and 1,000 shares at $41.82.
  • Transactions on October 26, 2026: Samsara BioCapital, L.P. acquired 48,988 shares and Samsara Opportunity Fund, L.P. acquired 97,982 shares, both at a weighted average price of $41.59.
  • Post-transaction beneficial ownership: Samsara BioCapital, L.P. held 6,380,517 shares and Samsara Opportunity Fund, L.P. held 723,020 shares following all reported transactions.
  • Disclaimer: Akkaraju disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein, according to the filing.
  • Prior disposition note: The filing states that shares held by Samsara BioCapital, L.P. prior to the reported transactions reflect a disposition of 83,585 shares in which Akkaraju had no pecuniary interest, described as exempt from reporting under Section 16.

Akkaraju's Fund Purchases Across Two Trading Days in October 2026

According to the Form 4 filed October 27, 2026, Director Srinivas Akkaraju reported six purchase transactions in Scholar Rock Holding Corp common stock executed through two affiliated entities: Samsara BioCapital, L.P. and Samsara Opportunity Fund, L.P. All transactions carried transaction code "P," indicating open-market purchases. The filing covers activity on October 23 and October 26, 2026.

On October 23, Samsara BioCapital, L.P. purchased 47,000 shares at a weighted average price of $41.31, with individual transaction prices ranging from $40.77 to $41.75, and an additional 500 shares at a weighted average of $41.82, with prices ranging from $41.78 to $41.85. On the same date, Samsara Opportunity Fund, L.P. purchased 94,000 shares at $41.31 and 1,000 shares at $41.82. On October 26, Samsara BioCapital, L.P. acquired 48,988 shares and Samsara Opportunity Fund, L.P. acquired 97,982 shares, each at a weighted average price of $41.59, with prices on that date ranging from $41.15 to $41.93, according to the filing.

The filing notes that Samsara BioCapital GP, LLC is the general partner of Samsara BioCapital, L.P. and may be deemed to beneficially own the securities held by that fund. Similarly, Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund, L.P. The filing states that Akkaraju "has voting and investment power over the securities held by Samsara LP" and the Opportunity Fund, and accordingly may be deemed to beneficially own those securities, while disclaiming ownership beyond his pecuniary interest. The filing also notes a Table I entry showing 27,971 shares disposed of directly, with no transaction date or price provided in the source text for that line.

What Was Disclosed

Director Srinivas Akkaraju disclosed purchases of Scholar Rock Holding Corp common stock on October 23 and October 26, 2026, through Samsara BioCapital, L.P. and Samsara Opportunity Fund, L.P., at weighted average prices ranging from $41.31 to $41.82 per share across the two trading days.